Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2015 Jan;65(1):54–61. doi: 10.1097/FJC.0000000000000163

Figure 1.

Figure 1

Erlotinib ± aprepitant treatment does not significantly alter the rate of animal weight gain versus control during 9 weeks of exposure. Erlotinib (starting 10 mg/kg/day, oral) and/or aprepitant (starting 2 mg/kg/day, oral) were administered in custom-prepared food. Data are means ± SEM of 5–7 rats per group.